ZAZZI MAURIZIO | Elenco docenti

Clemente, T., Torkjazi, G., Capra, N., Gagliardini, R., Cattelan, A.M., Lolatto, R., et al. (2026). Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 81(1) [10.1093/jac/dkaf415]. - dettaglio
Amodeo, D., Marchi, S., Fiaschi, L., Raucci, L., Biba, C., Salvestroni, V., et al. (2025). Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm). APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 91(6) [10.1128/aem.00403-25]. - dettaglio
Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Giacomelli, A., Capra, N., Lolatto, R., Gagliardini, R., Clemente, T., Calza, L., et al. (2025). All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry. CLINICAL INFECTIOUS DISEASES, 81(5), e370-e374 [10.1093/cid/ciaf421]. - dettaglio
Armenia, D., Marchegiani, G., Spagnuolo, V., Bellocchi, M.C., Galli, L., Clemente, T., et al. (2025). Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(11), 3101-3106 [10.1093/jac/dkaf349]. - dettaglio

Tutte le pubblicazioni